Long-Term Medical Resource Consumption of Radical Prostatectomy vs. Intensity-Modulated Radiotherapy for Old Patients With Prostate Cancer: A Nationwide Population-Based Cohort Study.

Front Med (Lausanne)

International Ph.D. Program in Biotech and Healthcare Management, School of Health Care Administration, College of Management, Taipei Medical University, Taipei, Taiwan.

Published: May 2022

AI Article Synopsis

  • The study compares long-term medical resource use between radical prostatectomy (RP) and intensity-modulated radiation therapy (IMRT) for elderly patients (≥80 years) with high-risk localized prostate cancer.
  • Researchers used propensity score matching and advanced statistical models to evaluate differences in post-treatment medical visits, reimbursements for urinary complications, and hospitalizations over a 5-year period.
  • Results indicated that patients undergoing IMRT had significantly more urology clinic visits and were more likely to experience treatment-related complications compared to those who had RP, particularly in the first few years post-treatment.

Article Abstract

Purpose: Few studies have compared the long-term medical resource consumption between radical prostatectomy (RP) and intensity-modulated radiation therapy (IMRT) among old (≥80 years) patients with localized prostate cancer (LPC), particularly in those at high risk of prostate adenocarcinoma.

Patients And Methods: The propensity score matching was conducted to investigate the medical expenditure of two therapeutic modalities (RP and IMRT) in elderly patients with high-risk LPC (HR-LPC). The generalized linear mixed and logistic regression models were employed to evaluate the number of postdischarge visits and medical reimbursement for urinary diseases or complications and the number of hospitalizations for treatment-related complications over 5 years after treatment, respectively.

Results: Significant differences were observed in the median or mean urology clinic visit numbers across the two therapeutic modalities from the first until fifth year post treatment ( < 0.0001). After adjustment for covariates, the mean difference [95% confidence interval (CI)] of urology clinic visit numbers between RP and IMRT was 13.07 (10.45-15.49, < 0.0001), 7.47 (8.01-14.92, < 0.0001), 8.24 (4.59-9.90, < 0.0001), 6.63 (3.55-11.70, < 0.0001), and 5.02 (1.12-8.73, < 0.0001) for the first, second, third, fourth, and fifth years, respectively. In the logistic regression multivariate model with adjustment for covariates [therapy type, age, diagnosis year, income, hospital area, hospital level (academic or nonacademic), clinical and pathological T-stage, grade (Gleason score), pretreatment PSA level (ng/ml), and D'Amico risk classification], the adjusted odds ratio (95% CI) of IMRT was 2.10 (1.37-2.56, = 0.0013), 1.55 (1.08-2.21, = 0.0151), 1.35 (1.08-2.21, = 0.0084), 1.24 (1.07-2.21, = 0.0071), and 1.09 (1.02-1.81, = 0.0379) for the first, second, third, fourth, and fifth years, respectively, compared with those of RP. The mean difference (95% CI) of total medical claims amounts of RP and IMRT between the RP and IMRT + ADT groups was 2,69,823 New Taiwan Dollars (NTD) (247,676-291,970, < 0.0001), 40,803 NTD (17,379-54,228, < 0.0001), 36,202 NTD (24,375-68,029, < 0.0001), 26,708 NTD (11,179-54,595, = 0.0321), and 12,173 NTD (17,140-41,487, = 0.0187) for the first, second, third, fourth, and fifth years, respectively.

Conclusion: The long-term medical resource consumption was higher in old men with HR-LPC undergoing IMRT than in those undergoing RP.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9113182PMC
http://dx.doi.org/10.3389/fmed.2022.843709DOI Listing

Publication Analysis

Top Keywords

long-term medical
12
medical resource
12
resource consumption
12
second third
12
third fourth
12
fourth years
12
00001
9
consumption radical
8
radical prostatectomy
8
prostatectomy intensity-modulated
8

Similar Publications

Objectives: This research aimed to compare the prostate cancer (PCa) features, survival rate, and functional outcomes after open suprapubic Radical Prostatectomy (RP) between younger men (≤ 55 years) and older men (> 55 years).

Methods: In this retrospective cohort study, we studied 134 patients with clinically localized PCa who underwent RP at our centers between 2011 and 2019, with 26 (19.40%) patients aged ≤ 55.

View Article and Find Full Text PDF

Distal tibial fractures are common lower-limb injuries and are generally associated with a high risk of postoperative complications, especially in patients with multiple medical comorbidities. This study sought to ascertain the efficacy of retrograde intramedullary tibial nails (RTN) for treating extra-articular distal tibial fractures in high-risk patients. Between January 2019 and December 2021, 13 patients considered at high risk for postoperative complications underwent RTN fixation.

View Article and Find Full Text PDF

Joint pain is the primary symptom of osteoarthritis (OA) and the main motivator for patients to seek medical care. OA-related pain significantly restricts joint function and diminishes quality of life. Despite the availability of various pain-relieving medications for OA, current treatment strategies often fall short in delivering adequate pain relief.

View Article and Find Full Text PDF

Despite enormous progress, advanced cancers are still one of the most serious medical problems in current society. Although various agents and therapeutic strategies with anticancer activity are known and used, they often fail to achieve satisfactory long-term patient outcomes and survival. Recently, immunotherapy has shown success in patients by harnessing important interactions between the immune system and cancer.

View Article and Find Full Text PDF

Introduction: Low grade appendiceal mucinous neoplasms (LAMN) are indolent tumors that lack invasive potential but may present as pseudomyxoma peritonei. Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) significantly improves both overall and recurrence free survival. While systemic chemotherapy is generally considered ineffective for LAMN, little literature is available to support this notion.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!